The fetal safety of clomiphene citrate: a population-based retrospective cohort study

Keyphrases

• Clomiphene Citrate 100%
• Population-based Retrospective Cohort Study 100%
• Fetal Safety 100%
• Major Congenital Malformations 71%
• Adjusted Odds Ratio 57%
• 95% Confidence Interval 57%
• Termination of Pregnancy 42%
• Malformation 28%
• Non-associated 28%
• Fetal Malformations 28%
• Medical Center 14%
• Pregnant Women 14%
• Maternal Age 14%
• Southern Israel 14%
• Large Population 14%
• Anencephaly 14%
• Giving Birth 14%
• Multiple Logistic Regression Model 14%
• Progesterone 14%
• First Month 14%
• Pregnancy in Diabetics 14%
• Fetal Anomalies 14%
• Esophageal Atresia 14%
• Gonadotropins 14%
• Combined Medication 14%
• Ovulation Induction 14%
• Organ Systems 14%
• Crudes Odds Ratio 14%
• Birth Hospitalization 14%

Medicine and Dentistry

• Retrospective Cohort Study 100%
• Congenital Malformation 100%
• Clomifene Citrate 100%
• Odds Ratio 71%
• Fetus Malformation 42%
• Gestational Diabetes 14%
• Observational Study 14%
• Conception 14%
• Anencephalus 14%
• Multivariate Logistic Regression Analysis 14%
• Maternal Age 14%
• Progesterone 14%
• Organ Systems 14%
• Esophageal Atresia 14%
• Gonadotropin 14%
• Ovulation Induction 14%
• Pregnant Woman 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Congenital Malformation 100%
• Cohort Study 100%
• Clomifene Citrate 100%
• Fetus Malformation 42%
• Pregnancy Diabetes Mellitus 14%
• Observational Study 14%
• Anencephalus 14%
• Esophagus Atresia 14%
• Gonadotropin 14%
• Progesterone 14%